Inversion of intron 22 of the factor VIIi gene in a girl with severe hemophilia a and Turner's syndrome
Chuansumrit, A.; Sasanakul, W.; Goodeve, A.; Treratvirapong, T.; Parinayok, R.; Pintadit, P.; Hathirat, P.
Thrombosis and Haemostasis 82(4): 1379
1999
ISSN/ISBN: 0340-6245 PMID: 10544944 Document Number: 507326
Document emailed within 1 workday
Related Documents
Sacchi, E.; Stefanile, C.; Tagliavacca, L.; Mannucci, P.M.; Bianchi Bonomi, A. 1992: Usefulness of determination of factor VIIi intron 7 polymorphism by a non-radioactive technique for carrier detection of hemophilia a Thrombosis and Haemostasis 68(5): 622-623Tizzano, E.F.; Soria, Jé.Manuel.; Coll, I.; Guzmán, B.; Cornet, Mónica.; Altisent, C.; Martorell, M.; Domenech, M.; del Río, E.; Fontcuberta, J.; Baiget, M. 2002: The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors Haematologica 87(3): 279-285
Ill, C.R.; Yang, C.Q.; Bidlingmaier, S.M.; Gonzales, J.N.; Burns, D.S.; Bartholomew, R.M.; Scuderi, P. 1997: Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 8 Suppl. 2: S23-S30
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Seita, I.; Shinozawa, K.; Otaki, M.; Fujita, S.; Suzuki, T.; Amano, K.; Inaba, H.; Fukutake, K. 2009: Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B Rinsho Byori. Japanese Journal of Clinical Pathology 57(5): 417-424
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62
Kochhan, L.; Lalloz, M.R.; Oldenburg, J.; McVey, J.H.; Olek, K.; Brackmann, H.H.; Tuddenham, E.G.; Schwaab, R. 1994: Haemophilia A diagnosis by automated fluorescent DNA detection of ten factor VIII intron 13 dinucleotide repeat alleles Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(4): 497-501
Mahasandana, C.; Patharathienskul, D.; Suvatte, V. 1993: Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl 1): 106-112
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Poort, S.R.; Briët, E.; Bertina, R.M.; Reitsma, P.H. 1990: Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B Thrombosis and Haemostasis 64(3): 379-384
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Bolland, J.; Lambotte, C. 1978: Factor VIIi in hemophilia and von Willebrand's disease Revue Medicale de Liege 33(8): 284-295
Schoppmann, A.; Waytes, A.T. 1996: Factor VIIi inhibitor and severity of hemophilia Thrombosis and Haemostasis 76(2): 280-281
Lopaciuk, S.; Ziemski, J.M. 1979: Treatment of patients with hemophilia a having antibodies to factor VIIi Acta Haematologica Polonica 10(2): 115-122
Hoyer, L.W.; Qian, J. 2000: Characterization of the immune response to factor VIIi using hemophilia A* mice Haematologica 85(10 Suppl): 100-102
Petrovic, M.; Derom, E.; Baele, G. 2000: Cyclosporine treatment of acquired hemophilia due to factor VIIi antibodies Haematologica 85(8): 895-896